Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MeteoSpasmyl in Irritable Bowel Syndrome
NCT01404923Phase 4Completed
- Sponsor
- Mayoly Spindler
- Start
- Dec 2009
- Primary completion
- Oct 2011
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of alverine citrate + simeticone in irritable bowel syndrome (IBS), sponsored by Mayoly Spindler. Started Dec 2009; status: completed.
02
Drugs
alverine citrate + simeticone
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT01404923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01404923.